Gabriel Morris is President and Chief Financial Officer of Immix Biopharma, a biopharmaceutical company dedicated to the development of impactful therapeutics, as patients are waiting.
Previously, Gabriel served as interim Chief Financial Officer at Zap Surgical Systems, a brain radiosurgery company, where he completed a growth financing round, and founded Alwaysraise, a healthcare investment and advisory firm. Prior to that, Gabriel led cross-border mergers and acquisitions transactions at Goldman Sachs & Co. and other global investment banks for more than a decade.
Gabriel earned his bachelor's degree in economics-philosophy from Columbia University in the City of New York, where he attended the Icahn School of Medicine at Mount Sinai Humanities and Medicine program.